172 related articles for article (PubMed ID: 36411088)
21. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.
Frankland MP; Dillman JR; Anton CG; Coley BD; Nasser MP; O'Hara SM; Li Y; Trout AT
Pediatr Radiol; 2022 Jun; 52(7):1306-1313. PubMed ID: 35229183
[TBL] [Abstract][Full Text] [Related]
23. Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment.
Gatos I; Drazinos P; Yarmenitis S; Theotokas I; Koskinas J; Koullias E; Mitranou A; Manesis E; Zoumpoulis PS
Ultrasound Q; 2022 Jun; 38(2):124-132. PubMed ID: 35353797
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.
Zhang B; Ding F; Chen T; Xia LH; Qian J; Lv GY
World J Gastroenterol; 2014 Dec; 20(47):17985-92. PubMed ID: 25548498
[TBL] [Abstract][Full Text] [Related]
25. Hepatic Steatosis Assessment with Ultrasound Small-Window Entropy Imaging.
Zhou Z; Tai DI; Wan YL; Tseng JH; Lin YR; Wu S; Yang KC; Liao YY; Yeh CK; Tsui PH
Ultrasound Med Biol; 2018 Jul; 44(7):1327-1340. PubMed ID: 29622501
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
Papatheodoridi M; Cholongitas E
Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease.
Lee SJ; Kim SU
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):523-530. PubMed ID: 31018719
[TBL] [Abstract][Full Text] [Related]
28. Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
Hsu PK; Wu LS; Su WW; Su PY; Chen YY; Hsu YC; Yen HH; Wu CL
PLoS One; 2021; 16(10):e0254892. PubMed ID: 34653177
[TBL] [Abstract][Full Text] [Related]
29. Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease.
Miele L; Zocco MA; Pizzolante F; De Matthaeis N; Ainora ME; Liguori A; Gasbarrini A; Grieco A; Rapaccini G
Metabolism; 2020 Nov; 112():154355. PubMed ID: 32916154
[TBL] [Abstract][Full Text] [Related]
30. Utility of quantitative ultrasound in community screening for hepatic steatosis.
Chang TY; Chang SH; Lin YH; Ho WC; Wang CY; Jeng WJ; Wan YL; Tsui PH
Ultrasonics; 2021 Mar; 111():106329. PubMed ID: 33338730
[TBL] [Abstract][Full Text] [Related]
31. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study.
Idilman IS; Celik A; Savas B; Idilman R; Karcaaltincaba M
Clin Radiol; 2021 Sep; 76(9):709.e13-709.e18. PubMed ID: 34266657
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
[TBL] [Abstract][Full Text] [Related]
33. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper.
Ferraioli G; Berzigotti A; Barr RG; Choi BI; Cui XW; Dong Y; Gilja OH; Lee JY; Lee DH; Moriyasu F; Piscaglia F; Sugimoto K; Wong GL; Wong VW; Dietrich CF
Ultrasound Med Biol; 2021 Oct; 47(10):2803-2820. PubMed ID: 34284932
[TBL] [Abstract][Full Text] [Related]
34. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
[TBL] [Abstract][Full Text] [Related]
35. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of Ultrasound in Fatty Liver Disease.
Karlas T; Blank V; Böhlig A
Ultraschall Med; 2021 Apr; 42(2):128-153. PubMed ID: 33622003
[TBL] [Abstract][Full Text] [Related]
37. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.
Thompson SM; Garg I; Ehman EC; Sheedy SP; Bookwalter CA; Carter RE; Roberts LR; Venkatesh SK
Br J Radiol; 2018 Dec; 91(1092):20180345. PubMed ID: 30074820
[TBL] [Abstract][Full Text] [Related]
38. What's New in Hepatic Steatosis.
Virarkar M; Szklaruk J; Jensen CT; Taggart MW; Bhosale P
Semin Ultrasound CT MR; 2021 Aug; 42(4):405-415. PubMed ID: 34130852
[TBL] [Abstract][Full Text] [Related]
39. Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation.
Huang YL; Cheng J; Wang Y; Xu XL; Wang SW; Wei L; Dong Y
Clin Hemorheol Microcirc; 2024; 86(1-2):51-61. PubMed ID: 37638422
[TBL] [Abstract][Full Text] [Related]
40. [Research Progress of Quantitative Ultrasound Assessment of Liver Steatosis in Non-alcoholic Fatty Liver Disease].
Chen J; Zhang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):827-832. PubMed ID: 34728047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
